Quercetin attenuates the cardiotoxicity of doxorubicin–cyclophosphamide regimen and potentiates its chemotherapeutic effect against triple-negative breast cancer | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Quercetin attenuates the cardiotoxicity of doxorubicin–cyclophosphamide regimen and potentiates its chemotherapeutic effect against triple-negative breast cancer

Authors:: Puwei Zhang; Jianing Zhang; Lin Zhao; Shizheng Li; Kun Li

Reference:: Phytotherapy Research; 2022; 36; 551-561

DOI:: 10.1002/ptr.7342

See Abstract

Key Words:: Doxorubicin; cyclophosphamide; combination therapy; triple negative breast cancer; quercetin; myocardial protection; anticancer; reactive oxygen species; ERK1/2

Back to index